Neuroimaging analyses have revealed increased right STG volume in subjects with autism, consistent with a recent finding of a more rightward asymmetry of the STG in individuals with autism
[12] [1] Scientific References Ozempic EPAR Product Information
Objectives This review highlights the dual metabolic and psychological impacts of GLP-1 and GIP agonists in diabetes and obesity management, emphasizing the need for a holistic, patient-centered approach to optimize treatment outcomes
Sunil Badve, a kidney specialist and professorial fellow at The George Institute for Global Health in Sydney, Australia
Brand names include Ozempic (approved for diabetes) and Wegovy (approved for weight loss)
Over time, this exploitative market expanded to include so-called GLP-1 products, such as gummies and patches, that do not contain GLP-1 ingredients